ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

BVC Batm Advanced Communications Ld

19.20
0.40 (2.13%)
25 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Batm Advanced Communications Ld LSE:BVC London Ordinary Share IL0010849045 ORD ILS0.01
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.40 2.13% 19.20 18.45 19.95 10,258 16:35:29
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Communications Services, Nec 122.83M -193k -0.0004 -470.00 81.98M

BATM Advanced Communications Ld Receipt of $14.5m investment in Ador Diagnostics (2141V)

05/04/2019 7:00am

UK Regulatory


Batm Advanced Communicat... (LSE:BVC)
Historical Stock Chart


From Apr 2019 to Apr 2024

Click Here for more Batm Advanced Communicat... Charts.

TIDMBVC

RNS Number : 2141V

BATM Advanced Communications Ld

05 April 2019

LEI: 213800FLQUB9J289RU66

5 April 2019

BATM Advanced Communications Limited

("BATM" or "the Group")

Receipt of $14.5m investment in Ador Diagnostics

First instalment under Investment Agreement to advance molecular diagnostics solution

Further to the announcement of 28 January 2019, BATM Advanced Communications Limited (LSE: BVC), a leading provider of real-time technologies for networking solutions and medical laboratory systems, is pleased to announce the completion of the initial investment of $14.5m ("Initial Investment") under the conditional subscription and shareholders' agreement (the "Investment Agreement") for up to $30m to provide additional funds for the commercialisation of the molecular biology-based solutions being developed by Ador Diagnostics.

Pursuant to the Investment Agreement, following the Initial Investment, Ador Diagnostics has an enterprise value of $44.5m and BATM has an ownership interest of 38.2%.

A further $15.5m (at a valuation that will be a 33.3% premium to the post-Initial Investment enterprise valuation) is expected to be funded by the end of 2020, subject to certain milestones being achieved.

Dr Zvi Marom, Chief Executive Officer of BATM, said: "We are delighted to have received the Initial Investment to accelerate the commercialisation of our breakthrough NATlab system, which we believe will revolutionise the point-of-care medical diagnostics industry. Since signing the Investment Agreement, we have continued to make progress in our final preparations ahead of in-hospital installation. We are very excited about the tremendous potential of this unique molecular biology-based diagnostics solution."

Enquiries:

 
 BATM Advanced Communications 
 Dr. Zvi Marom, Chief Executive Officer                +972 9866 2525 
                                                      --------------- 
 Moti Nagar, Chief Financial Officer 
                                                      --------------- 
 
 Shore Capital Stockbrokers Limited (Broker to 
  the Group) 
                                                      --------------- 
                                                       +44 20 7408 
 Mark Percy, Anita Ghanekar                             4050 
                                                      --------------- 
 
 SPARK Advisory Partners Limited (Financial Adviser 
  to the Group) 
                                                      --------------- 
                                                       +44 20 3368 
 Mark Brady, Andrew Emmott                              3550 
                                                      --------------- 
 
 Luther Pendragon (Financial PR) 
                                                      --------------- 
                                                       +44 20 7618 
 Harry Chathli, Claire Norbury, Joe Quinlan             9100 
                                                      --------------- 
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

MSCBIGDSRDGBGCS

(END) Dow Jones Newswires

April 05, 2019 02:00 ET (06:00 GMT)

1 Year Batm Advanced Communicat... Chart

1 Year Batm Advanced Communicat... Chart

1 Month Batm Advanced Communicat... Chart

1 Month Batm Advanced Communicat... Chart

Your Recent History

Delayed Upgrade Clock